Get the latest Science News and Discoveries

Aficamten trial brings positive news for patients living with non-obstructive hypertrophic cardiomyopathy


Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.

None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of patients

patients

Photo of Aficamten trial

Aficamten trial

Photo of positive news

positive news

Related news:

News photo

Patients are missing out on the cardiovascular benefits of blood pressure-lowering medicines

News photo

Cancer biosimilars associated with lower costs for insurers and patients, UCLA study finds

News photo

Dartmouth Health researchers identify additional risk for patients with tick-borne alpha-gal syndrome apart from meat allergy